The Claim
Genetic deletion or pharmacological inhibition of CaMKK2 in adult mouse skeletal muscle does not impair contraction-stimulated AMPK phosphorylation at Thr172 or glucose uptake, indicating that CaMKK2 is not required for these processes under normal physiological conditions.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adult mice, blocking or removing the CaMKK2 protein does not reduce the activation of AMPK or the uptake of glucose in skeletal muscle during muscle contraction.
See the scientific wording
In adult mouse skeletal muscle, genetic deletion or pharmacological inhibition of CaMKK2 does not impair contraction-stimulated AMPK phosphorylation at Thr172 or glucose uptake, indicating that CaMKK2 is not required for these processes under normal physiological conditions.
When muscle contracts, it uses up energy, which causes a rise in AMP and ADP levels. This change triggers LKB1 to add a phosphate group to AMPK at a specific spot, turning it on. Activated AMPK then signals the muscle to take in more sugar from the blood to make more energy, all without needing CaMKK2.
What the research says
1 studyWhen scientists removed or blocked the CaMKK2 protein in mouse muscles, the muscles still activated AMPK and took up sugar normally during contraction — meaning CaMKK2 isn’t needed for this process. Even fake drugs that couldn’t block CaMKK2 still stopped sugar uptake, proving earlier results were mistakes.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.